TPIS_HUMAN - dbPTM
TPIS_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TPIS_HUMAN
UniProt AC P60174
Protein Name Triosephosphate isomerase
Gene Name TPI1
Organism Homo sapiens (Human).
Sequence Length 286
Subcellular Localization
Protein Description
Protein Sequence MAEDGEEAEFHFAALYISGQWPRLRADTDLQRLGSSAMAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
14UbiquitinationEAEFHFAALYISGQW
CCEEEEEEEHHCCCC
10.4321890473
14AcetylationEAEFHFAALYISGQW
CCEEEEEEEHHCCCC
10.4319608861
14 (in isoform 1)Acetylation-10.43-
16PhosphorylationEFHFAALYISGQWPR
EEEEEEEHHCCCCHH
6.5725693802
21PhosphorylationALYISGQWPRLRADT
EEHHCCCCHHCCCCC
5.4119664995
21 (in isoform 1)Phosphorylation-5.4121406692
28PhosphorylationWPRLRADTDLQRLGS
CHHCCCCCCHHHHCC
37.3120068231
28 (in isoform 1)Phosphorylation-37.31-
35PhosphorylationTDLQRLGSSAMAPSR
CCHHHHCCCCCCCCC
21.3730622161
36PhosphorylationDLQRLGSSAMAPSRK
CHHHHCCCCCCCCCC
21.9220860994
36 (in isoform 3)O-linked_Glycosylation-21.9223301498
38 (in isoform 1)Phosphorylation-6.4321406692
41PhosphorylationGSSAMAPSRKFFVGG
CCCCCCCCCCEEECC
38.2720860994
41 (in isoform 3)O-linked_Glycosylation-38.2723301498
432-HydroxyisobutyrylationSAMAPSRKFFVGGNW
CCCCCCCCEEECCCC
47.71-
43AcetylationSAMAPSRKFFVGGNW
CCCCCCCCEEECCCC
47.7123954790
43UbiquitinationSAMAPSRKFFVGGNW
CCCCCCCCEEECCCC
47.7121890473
46 (in isoform 1)Phosphorylation-12.3521406692
51AcetylationFFVGGNWKMNGRKQS
EEECCCCCCCCCCCC
26.8719608861
51MethylationFFVGGNWKMNGRKQS
EEECCCCCCCCCCCC
26.8722632985
51UbiquitinationFFVGGNWKMNGRKQS
EEECCCCCCCCCCCC
26.8721890473
562-HydroxyisobutyrylationNWKMNGRKQSLGELI
CCCCCCCCCCHHHHH
45.71-
56UbiquitinationNWKMNGRKQSLGELI
CCCCCCCCCCHHHHH
45.71-
58PhosphorylationKMNGRKQSLGELIGT
CCCCCCCCHHHHHHH
41.1829255136
59UbiquitinationMNGRKQSLGELIGTL
CCCCCCCHHHHHHHH
5.9821890473
59 (in isoform 1)Ubiquitination-5.9821890473
65PhosphorylationSLGELIGTLNAAKVP
CHHHHHHHHHHCCCC
15.1723927012
68NitrationELIGTLNAAKVPADT
HHHHHHHHCCCCCCC
16.27-
69UbiquitinationLIGTLNAAKVPADTE
HHHHHHHCCCCCCCE
16.5921890473
69 (in isoform 1)Ubiquitination-16.5921890473
70UbiquitinationIGTLNAAKVPADTEV
HHHHHHCCCCCCCEE
46.47-
71PhosphorylationGTLNAAKVPADTEVV
HHHHHCCCCCCCEEE
3.9720068231
71 (in isoform 1)Phosphorylation-3.97-
75PhosphorylationAAKVPADTEVVCAPP
HCCCCCCCEEEECCC
32.5528464451
79GlutathionylationPADTEVVCAPPTAYI
CCCCEEEECCCCCHH
5.9322555962
79S-palmitoylationPADTEVVCAPPTAYI
CCCCEEEECCCCCHH
5.9329575903
80PhosphorylationADTEVVCAPPTAYID
CCCEEEECCCCCHHH
11.0719413330
80 (in isoform 1)Phosphorylation-11.07-
83PhosphorylationEVVCAPPTAYIDFAR
EEEECCCCCHHHHHH
30.9128796482
85PhosphorylationVCAPPTAYIDFARQK
EECCCCCHHHHHHHH
11.9628796482
962-HydroxyisobutyrylationARQKLDPKIAVAAQN
HHHHCCHHHHHEECC
42.86-
96AcetylationARQKLDPKIAVAAQN
HHHHCCHHHHHEECC
42.8623236377
96UbiquitinationARQKLDPKIAVAAQN
HHHHCCHHHHHEECC
42.8621890473
104GlutathionylationIAVAAQNCYKVTNGA
HHHEECCEEEECCCC
2.0122555962
104S-palmitoylationIAVAAQNCYKVTNGA
HHHEECCEEEECCCC
2.0129575903
105Nitrated tyrosineAVAAQNCYKVTNGAF
HHEECCEEEECCCCC
18.95-
105PhosphorylationAVAAQNCYKVTNGAF
HHEECCEEEECCCCC
18.9528152594
106AcetylationVAAQNCYKVTNGAFT
HEECCEEEECCCCCC
44.7925953088
106MethylationVAAQNCYKVTNGAFT
HEECCEEEECCCCCC
44.7970215
106PhosphorylationVAAQNCYKVTNGAFT
HEECCEEEECCCCCC
44.79-
106UbiquitinationVAAQNCYKVTNGAFT
HEECCEEEECCCCCC
44.7921890473
108PhosphorylationAQNCYKVTNGAFTGE
ECCEEEECCCCCCCC
24.6321712546
112AcetylationYKVTNGAFTGEISPG
EEECCCCCCCCCCCC
10.7819608861
112MethylationYKVTNGAFTGEISPG
EEECCCCCCCCCCCC
10.7819608861
112UbiquitinationYKVTNGAFTGEISPG
EEECCCCCCCCCCCC
10.7819608861
113PhosphorylationKVTNGAFTGEISPGM
EECCCCCCCCCCCCC
33.1125159151
117PhosphorylationGAFTGEISPGMIKDC
CCCCCCCCCCCEECC
15.8829255136
120SulfoxidationTGEISPGMIKDCGAT
CCCCCCCCEECCCCE
3.8021406390
122AcetylationEISPGMIKDCGATWV
CCCCCCEECCCCEEE
37.7726051181
122UbiquitinationEISPGMIKDCGATWV
CCCCCCEECCCCEEE
37.77-
124GlutathionylationSPGMIKDCGATWVVL
CCCCEECCCCEEEEE
3.2022555962
124S-palmitoylationSPGMIKDCGATWVVL
CCCCEECCCCEEEEE
3.2029575903
127PhosphorylationMIKDCGATWVVLGHS
CEECCCCEEEEEECC
12.2228857561
134PhosphorylationTWVVLGHSERRHVFG
EEEEEECCCCCCCCC
30.8828857561
137MethylationVLGHSERRHVFGESD
EEECCCCCCCCCCCH
26.69115918793
142UbiquitinationERRHVFGESDELIGQ
CCCCCCCCCHHHHHH
43.4821890473
142 (in isoform 1)Ubiquitination-43.4821890473
143PhosphorylationRRHVFGESDELIGQK
CCCCCCCCHHHHHHH
36.4419764811
149UbiquitinationESDELIGQKVAHALA
CCHHHHHHHHHHHHH
30.0121890473
149SuccinylationESDELIGQKVAHALA
CCHHHHHHHHHHHHH
30.01-
149 (in isoform 1)Ubiquitination-30.0121890473
156UbiquitinationQKVAHALAEGLGVIA
HHHHHHHHHCCCEEE
15.0321890473
156AcetylationQKVAHALAEGLGVIA
HHHHHHHHHCCCEEE
15.0319608861
156SuccinylationQKVAHALAEGLGVIA
HHHHHHHHHCCCEEE
15.03-
156UbiquitinationQKVAHALAEGLGVIA
HHHHHHHHHCCCEEE
15.0319608861
156 (in isoform 1)Ubiquitination-15.0321890473
159PhosphorylationAHALAEGLGVIACIG
HHHHHHCCCEEEEEE
3.59-
160UbiquitinationHALAEGLGVIACIGE
HHHHHCCCEEEEEEC
21.4621890473
160 (in isoform 1)Ubiquitination-21.4621890473
164GlutathionylationEGLGVIACIGEKLDE
HCCCEEEEEECCCCH
2.5622555962
164S-palmitoylationEGLGVIACIGEKLDE
HCCCEEEEEECCCCH
2.5629575903
1682-HydroxyisobutyrylationVIACIGEKLDEREAG
EEEEEECCCCHHCCC
56.90-
168AcetylationVIACIGEKLDEREAG
EEEEEECCCCHHCCC
56.9026051181
168UbiquitinationVIACIGEKLDEREAG
EEEEEECCCCHHCCC
56.90-
172MethylationIGEKLDEREAGITEK
EECCCCHHCCCCCCE
38.44115918797
173PhosphorylationGEKLDEREAGITEKV
ECCCCHHCCCCCCEE
49.56-
175UbiquitinationKLDEREAGITEKVVF
CCCHHCCCCCCEEEE
23.6921890473
175UbiquitinationKLDEREAGITEKVVF
CCCHHCCCCCCEEEE
23.6921139048
175 (in isoform 1)Ubiquitination-23.6921890473
177PhosphorylationDEREAGITEKVVFEQ
CHHCCCCCCEEEEEE
28.92-
1792-HydroxyisobutyrylationREAGITEKVVFEQTK
HCCCCCCEEEEEEEE
34.74-
179AcetylationREAGITEKVVFEQTK
HCCCCCCEEEEEEEE
34.7423954790
179SumoylationREAGITEKVVFEQTK
HCCCCCCEEEEEEEE
34.7425114211
179UbiquitinationREAGITEKVVFEQTK
HCCCCCCEEEEEEEE
34.7421890473
1862-HydroxyisobutyrylationKVVFEQTKVIADNVK
EEEEEEEEEEECCCC
31.19-
186AcetylationKVVFEQTKVIADNVK
EEEEEEEEEEECCCC
31.1923954790
186SuccinylationKVVFEQTKVIADNVK
EEEEEEEEEEECCCC
31.19-
186SuccinylationKVVFEQTKVIADNVK
EEEEEEEEEEECCCC
31.1921890473
186UbiquitinationKVVFEQTKVIADNVK
EEEEEEEEEEECCCC
31.19-
188UbiquitinationVFEQTKVIADNVKDW
EEEEEEEEECCCCCH
4.2021890473
188AcetylationVFEQTKVIADNVKDW
EEEEEEEEECCCCCH
4.2019608861
188 (in isoform 1)Acetylation-4.20-
188 (in isoform 1)Ubiquitination-4.2021890473
1932-HydroxyisobutyrylationKVIADNVKDWSKVVL
EEEECCCCCHHHEEE
60.79-
193AcetylationKVIADNVKDWSKVVL
EEEECCCCCHHHEEE
60.7923954790
193SuccinylationKVIADNVKDWSKVVL
EEEECCCCCHHHEEE
60.79-
193SuccinylationKVIADNVKDWSKVVL
EEEECCCCCHHHEEE
60.7923954790
193UbiquitinationKVIADNVKDWSKVVL
EEEECCCCCHHHEEE
60.79-
194UbiquitinationVIADNVKDWSKVVLA
EEECCCCCHHHEEEE
51.0721890473
194AcetylationVIADNVKDWSKVVLA
EEECCCCCHHHEEEE
51.0719608861
194MethylationVIADNVKDWSKVVLA
EEECCCCCHHHEEEE
51.0724129315
194SuccinylationVIADNVKDWSKVVLA
EEECCCCCHHHEEEE
51.07-
194 (in isoform 1)Acetylation-51.07-
194 (in isoform 1)Ubiquitination-51.0721890473
195PhosphorylationIADNVKDWSKVVLAY
EECCCCCHHHEEEEE
8.3720068231
195 (in isoform 1)Phosphorylation-8.37-
196PhosphorylationADNVKDWSKVVLAYE
ECCCCCHHHEEEEEE
26.2128857561
197UbiquitinationDNVKDWSKVVLAYEP
CCCCCHHHEEEEEEE
31.9121890473
198PhosphorylationNVKDWSKVVLAYEPV
CCCCHHHEEEEEEEE
3.3920068231
198 (in isoform 1)Phosphorylation-3.39-
202PhosphorylationWSKVVLAYEPVWAIG
HHHEEEEEEEEEEEC
19.3228796482
204PhosphorylationKVVLAYEPVWAIGTG
HEEEEEEEEEEECCC
17.8020068231
204 (in isoform 1)Phosphorylation-17.80-
209NitrationYEPVWAIGTGKTATP
EEEEEEECCCCCCCH
22.22-
210PhosphorylationEPVWAIGTGKTATPQ
EEEEEECCCCCCCHH
29.4128152594
212AcetylationVWAIGTGKTATPQQA
EEEECCCCCCCHHHH
34.5225953088
212PhosphorylationVWAIGTGKTATPQQA
EEEECCCCCCCHHHH
34.5223186163
212UbiquitinationVWAIGTGKTATPQQA
EEEECCCCCCCHHHH
34.5221890473
213PhosphorylationWAIGTGKTATPQQAQ
EEECCCCCCCHHHHH
36.7925159151
214PhosphorylationAIGTGKTATPQQAQE
EECCCCCCCHHHHHH
22.2924275569
215PhosphorylationIGTGKTATPQQAQEV
ECCCCCCCHHHHHHH
27.1928985074
218S-nitrosylationGKTATPQQAQEVHEK
CCCCCHHHHHHHHHH
46.3319483679
223PhosphorylationPQQAQEVHEKLRGWL
HHHHHHHHHHHHHHH
26.2224275569
2252-HydroxyisobutyrylationQAQEVHEKLRGWLKS
HHHHHHHHHHHHHHH
28.71-
225AcetylationQAQEVHEKLRGWLKS
HHHHHHHHHHHHHHH
28.7116916647
225UbiquitinationQAQEVHEKLRGWLKS
HHHHHHHHHHHHHHH
28.7121890473
231AcetylationEKLRGWLKSNVSDAV
HHHHHHHHHCHHHHH
33.2119608861
231MalonylationEKLRGWLKSNVSDAV
HHHHHHHHHCHHHHH
33.2126320211
231MethylationEKLRGWLKSNVSDAV
HHHHHHHHHCHHHHH
33.2124129315
231SuccinylationEKLRGWLKSNVSDAV
HHHHHHHHHCHHHHH
33.21-
231UbiquitinationEKLRGWLKSNVSDAV
HHHHHHHHHCHHHHH
33.21-
232PhosphorylationKLRGWLKSNVSDAVA
HHHHHHHHCHHHHHH
40.0529255136
235PhosphorylationGWLKSNVSDAVAQST
HHHHHCHHHHHHHCC
24.8929255136
238UbiquitinationKSNVSDAVAQSTRII
HHCHHHHHHHCCEEE
6.3021890473
238AcetylationKSNVSDAVAQSTRII
HHCHHHHHHHCCEEE
6.3019608861
238 (in isoform 1)Acetylation-6.30-
238 (in isoform 1)Ubiquitination-6.3021890473
241PhosphorylationVSDAVAQSTRIIYGG
HHHHHHHCCEEEECC
15.2020068231
242PhosphorylationSDAVAQSTRIIYGGS
HHHHHHCCEEEECCC
17.5120068231
246Nitrated tyrosineAQSTRIIYGGSVTGA
HHCCEEEECCCCCCH
17.05-
246PhosphorylationAQSTRIIYGGSVTGA
HHCCEEEECCCCCCH
17.0523927012
249PhosphorylationTRIIYGGSVTGATCK
CEEEECCCCCCHHHH
16.4923401153
251PhosphorylationIIYGGSVTGATCKEL
EEECCCCCCHHHHHH
23.8530266825
254PhosphorylationGGSVTGATCKELASQ
CCCCCCHHHHHHHCC
26.0023927012
255S-nitrosocysteineGSVTGATCKELASQP
CCCCCHHHHHHHCCC
2.98-
255GlutathionylationGSVTGATCKELASQP
CCCCCHHHHHHHCCC
2.9822555962
256PhosphoglycerylationSVTGATCKELASQPD
CCCCHHHHHHHCCCC
51.94-
256UbiquitinationSVTGATCKELASQPD
CCCCHHHHHHHCCCC
51.94-
260PhosphorylationATCKELASQPDVDGF
HHHHHHHCCCCCCCE
55.6728857561
273PhosphorylationGFLVGGASLKPEFVD
CEEECCCCCCHHHHH
39.9528857561
275AcetylationLVGGASLKPEFVDII
EECCCCCCHHHHHHH
39.7519608861
275MalonylationLVGGASLKPEFVDII
EECCCCCCHHHHHHH
39.7526320211
275UbiquitinationLVGGASLKPEFVDII
EECCCCCCHHHHHHH
39.75-
285AcetylationFVDIINAKQ------
HHHHHCCCC------
52.6470211
285SuccinylationFVDIINAKQ------
HHHHHCCCC------
52.6423954790
285UbiquitinationFVDIINAKQ------
HHHHHCCCC------
52.64-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of TPIS_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TPIS_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TPIS_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SETB1_HUMANSETDB1physical
16169070
TPIS_HUMANTPI1physical
8609635
A4_HUMANAPPphysical
21832049
RL40_HUMANUBA52physical
22939629
VINC_HUMANVCLphysical
22939629
ALDR_HUMANAKR1B1physical
26344197
AN32E_HUMANANP32Ephysical
26344197
ASSY_HUMANASS1physical
26344197
CRIP1_HUMANCRIP1physical
26344197
ESTD_HUMANESDphysical
26344197
HNRPR_HUMANHNRNPRphysical
26344197
NDUV1_HUMANNDUFV1physical
26344197
PGM2_HUMANPGM2physical
26344197
PGM2L_HUMANPGM2L1physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
615512Triosephosphate isomerase deficiency (TPID)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TPIS_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-51; LYS-225; LYS-231 ANDLYS-275, AND MASS SPECTROMETRY.
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-225, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58 AND SER-117, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58 AND SER-117, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND MASSSPECTROMETRY.
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment.";
Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
J. Proteome Res. 7:5167-5176(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND MASSSPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND MASSSPECTROMETRY.
"Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction.";
Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
Mol. Cell. Proteomics 6:1952-1967(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND MASSSPECTROMETRY.
"Phosphoproteomic analysis of the human pituitary.";
Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.;
Pituitary 9:109-120(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND MASSSPECTROMETRY.

TOP